Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the …
C Asseburg, M Frank, CH Köhne, JT Hartmann… - Clinical …, 2011 - Elsevier
Background In patients with metastases limited to the liver (liver-limited disease [LLD]),
effective therapies such as monoclonal antibodies combined with chemotherapy may …
effective therapies such as monoclonal antibodies combined with chemotherapy may …
Survival analysis of the CEAwatch multicentre clustered randomized trial
CJ Verberne, Z Zhan, ER Van den Heuvel… - Journal of British …, 2017 - academic.oup.com
Abstract Background The CEAwatch randomized trial showed that follow-up with intensive
carcinoembryonic antigen (CEA) monitoring (CEAwatch protocol) was better than care as …
carcinoembryonic antigen (CEA) monitoring (CEAwatch protocol) was better than care as …
Lymphatic drainage of the liver and its implications in the management of colorectal cancer liver metastases
RM Lupinacci, F Paye, FF Coelho, JAP Kruger… - Updates in surgery, 2014 - Springer
The liver is the most common site of distant metastases in patients with colorectal cancer.
Surgery represents the mainstream for curative treatment of colorectal cancer liver …
Surgery represents the mainstream for curative treatment of colorectal cancer liver …
[HTML][HTML] Advances in the understanding and treatment of colorectal cancer
K Soreide, M Berg, BS Skudal… - Discovery …, 2011 - discoverymedicine.com
Colorectal cancer (CRC) is a common malignancy and remains a formidable health burden
in the world. Surgery is the cornerstone for curative treatment, and surgical technique has …
in the world. Surgery is the cornerstone for curative treatment, and surgical technique has …
Is cure possible after sequential resection of hepatic and pulmonary metastases from colorectal cancer?
M Rajakannu, P Magdeleinat, E Vibert, O Ciacio… - Clinical Colorectal …, 2018 - Elsevier
Background Surgical resection is an established therapeutic strategy for colorectal cancer
(CRC) metastasis. However, controversies exist when CRC liver and lung metastases …
(CRC) metastasis. However, controversies exist when CRC liver and lung metastases …
[HTML][HTML] Benefits of repeated resections for liver and lung metastases from colorectal cancer
KM Yang, IJ Park, JL Lee, CW Kim, YS Yoon… - Asian Journal of …, 2020 - Elsevier
Objective We aimed to evaluate oncological outcomes after repeat metastasectomies in
patients having undergone previous resections for colorectal cancer metastases. Methods …
patients having undergone previous resections for colorectal cancer metastases. Methods …
[HTML][HTML] Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System
LR Belur, KM Podetz-Pedersen, BS Sorenson, AH Hsu… - Molecular cancer, 2011 - Springer
Background Metastatic colon cancer is one of the leading causes of cancer-related death
worldwide, with disease progression and metastatic spread being closely associated with …
worldwide, with disease progression and metastatic spread being closely associated with …
Positron emission tomography-computed tomography for patients with recurrent colorectal liver metastases: impact on restaging and treatment planning
Background The impact of fluorodeoxyglucose positron emission tomography–computed
tomography (PET-CT) for patients with colorectal liver metastases (CLM) still is debated. Its …
tomography (PET-CT) for patients with colorectal liver metastases (CLM) still is debated. Its …
[HTML][HTML] Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer
R Yokoi, JY Tajima, M Fukada, H Hayashi, M Kuno… - Cancers, 2023 - mdpi.com
Simple Summary Colorectal cancer is a prevalent disease, often progressing to metastatic
stages. A subgroup of patients displaying oligometastases presents a unique opportunity for …
stages. A subgroup of patients displaying oligometastases presents a unique opportunity for …
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC
EMV de Cuba, VJ Verwaal, IHJT de Hingh… - Annals of surgical …, 2014 - Springer
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) has improved the survival in selected colorectal cancer patients with peritoneal …
(HIPEC) has improved the survival in selected colorectal cancer patients with peritoneal …